Thursday, February 08, 2018 10:08:37 AM
All of this while entirely fluffing off any risk whatsoever with, it's biotech. Well it's not. It's Pluristem. Want to take a look at the risks, read the Edison report. Don't just look at the parts you want to hear.
Look at the part that talks about the most potential beneficial patients that enrolled in the hip fracture study. The questioning of the size of that market. The need for future dilution. The huge risk of jumping to stage 3 trials. The risk of having zero statistically significant numbers in any human trials with results. Others as well.
And let's not forget the giant risk of putting your money in the hands of people who are incapable of running a Biotech company. You know, with all the questionable clowns and how nobody on this board can come up with any reason whatsoever that justifies their belief that they CAN run a company. Some feeble attempts by one, but easily shot down.
Ask yourself this. How or why would any retail investor try to own 200,000 shares at over a quarter of a million dollars. Someone who is absolutely loaded maybe. But if that were the case, does anyone really think they'd be wasting their time posting here? Not likely.
I'm not sure what you mean by "I'll reconsider" there Happy. Not sure what you read of Zzatt's post that has given you renewed confidence in Pluristem. But it just proves my point.
Not sure what being under $1.40 should be called now. Steal of the century. But trying to lure investors in during pumps and all the way down should be called crime of the century.
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM